Fudan-Zhangjiang Bio-Pharma's H1 Profit Marginally Increases as Revenue Plunges
Fudan-Zhangjiang Bio-Pharma's H1 Profit Marginally Increases as Revenue Plunges
复旦张江生物医药的H1净利润略有增长，营业收入大幅下降。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册